Abstract

You have accessJournal of UrologyCME1 Apr 2023MP45-15 THE PANDEMIC, TELEMEDICINE, AND ANDROLOGY: WHAT HAVE WE LEARNED? Muhammed A. Moukhtar Hammad, Adnan El-Achkar, Tuan Nguyen, David W. Barham, Lawrence Jenkins, and Faysal Yafi Muhammed A. Moukhtar HammadMuhammed A. Moukhtar Hammad More articles by this author , Adnan El-AchkarAdnan El-Achkar More articles by this author , Tuan NguyenTuan Nguyen More articles by this author , David W. BarhamDavid W. Barham More articles by this author , Lawrence JenkinsLawrence Jenkins More articles by this author , and Faysal YafiFaysal Yafi More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000003291.15AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Telemedicine has gained wide acceptance during the COVID-19 pandemic. Worldwide lockdowns made this interface an indispensable one for patient care. Recent evidence suggests that urology patients were receptive to telemedicine; however, no systematic review has been done to date on andrology patients in particular and their perception of telemedicine. METHODS: Three electronic databases: PubMed, Scopus, and Web of Science, were searched from their inception until June 2022 for relevant articles. Two independent teams reviewed abstracts and extracted data from the selected manuscripts. A meta-analysis was completed in line with PRISMA 2020 and AMSTAR Guidelines. For our study, we limited telemedicine to communication through videoconferencing or telephone encounters between patients and medical professionals. Positive response to telemedicine was defined as patients “wishing for telemedicine consultation”, “preferring telemedicine over in person”, “accepting the current telemedicine arrangement”, “having needs addressed with teleconsultation”, or “willingness to do a teleconsultation”. RESULTS: Of the 1128 retrieved abstracts, 56 underwent full-text review and 12 were included in the final analysis, comprising a total cohort of >4021 cases. All 8 studies that assessed perception of andrology patients to telemedicine showed that most patients had “positive perception”. Telemedicine was shown to save an average cost of $149-252/patient. Pooled analyses of positive response to telemedicine were 68.7% (95% CI = 49.4 – 83.1%, p=0.057) and of patients who recommended telemedicine were 65.1% (95% CI = 18.4 – 93.9%, p=0.577). 84.6% pooled proportion for recommending video compared to 38.9 % pooled proportion for recommending telephone practice, p=0.035. In the telephone-only encounters, 27.1% of patients preferred in-person visits as security and privacy of any mode of telecommunication were of concern. CONCLUSIONS: Most patients have a positive perception of telemedicine, particularly with videoconferencing and less so with telephone visits. Telemedicine will plausibly continue to be integral in andrology practice. Source of Funding: None © 2023 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 209Issue Supplement 4April 2023Page: e627 Advertisement Copyright & Permissions© 2023 by American Urological Association Education and Research, Inc.MetricsAuthor Information Muhammed A. Moukhtar Hammad More articles by this author Adnan El-Achkar More articles by this author Tuan Nguyen More articles by this author David W. Barham More articles by this author Lawrence Jenkins More articles by this author Faysal Yafi More articles by this author Expand All Advertisement PDF downloadLoading ...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call